Cargando…

The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy

BACKGROUND: Astragaloside IV is the most important bioactive component of Radix Astragali. Previous studies have shown that astragaloside IV plays an important role in the control of early- and mid-stage diabetes and late diabetic nephropathy. However, it is disappointing that the in vivo solubility...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ziyu, Yang, Wei, Yang, Yong, Wu, Jianbo, Luo, Pei, Liu, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932932/ https://www.ncbi.nlm.nih.gov/pubmed/35308255 http://dx.doi.org/10.2147/DDDT.S346546

Ejemplares similares

Astragaloside IV Derivative (LS-102) Alleviated Myocardial Ischemia Reperfusion Injury by Inhibiting Drp1(Ser616) Phosphorylation-Mediated Mitochondrial Fission
por: Chen, Li, et al.
Publicado: (2020)

Astragaloside IV ameliorates diabetic nephropathy by modulating the mitochondrial quality control network
por: Liu, Xinhui, et al.
Publicado: (2017)

Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome-mediated inflammation
por: Feng, Hui, et al.
Publicado: (2021)

Astragaloside IV ameliorates renal injury in db/db mice
por: Sun, Huili, et al.
Publicado: (2016)

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
por: Sun, Chuang, et al.
Publicado: (2021)

Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
por: Zhang, Yudi, et al.
Publicado: (2020)

Ameliorating the Effect of Astragaloside IV on Learning and Memory Deficit after Chronic Cerebral Hypoperfusion in Rats
por: Kim, Sooyong, et al.
Publicado: (2015)

Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts
por: Wang, Zhen-Fei, et al.
Publicado: (2017)

Astragaloside IV ameliorates fat metabolism in the liver of ageing mice through targeting mitochondrial activity
por: Luo, Zhixiao, et al.
Publicado: (2021)

THE LS-ANTIGEN OF VACCINIA : IV. CHEMICAL ANALYSIS OF LS AND THE EFFECT OF CHYMOTRYPSIN ON LS
por: Smadel, Joseph E., et al.
Publicado: (1943)

Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathy
por: Meng, LQ, et al.
Publicado: (2011)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Astragaloside IV ameliorates allergic inflammation by inhibiting key initiating factors in the initial stage of sensitization
por: Bao, Kai-fan, et al.
Publicado: (2016)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
por: Yang, Chunkun, et al.
Publicado: (2023)

Astragaloside IV ameliorates peritoneal fibrosis by promoting PGC‐1α to reduce apoptosis in vitro and in vivo
por: Xie, Mingxia, et al.
Publicado: (2023)

Molecular mechanisms of astragaloside-IV in cancer therapy (Review)
por: Chen, Tianqi, et al.
Publicado: (2021)

Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress
por: Meng, Peipei, et al.
Publicado: (2021)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress
por: Wang, Zeng Si, et al.
Publicado: (2015)

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
por: Zhao, Zhen Xiong, et al.
Publicado: (2022)

Astragaloside IV ameliorates acute pancreatitis in rats by inhibiting the activation of nuclear factor-κB
por: QIU, LEI, et al.
Publicado: (2015)

Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456
por: Wan, Jingjing, et al.
Publicado: (2023)

Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-β1/Smad3 Signaling
por: Tong, Jiahuan, et al.
Publicado: (2021)

Astragalosidic Acid: A New Water-Soluble Derivative of Astragaloside IV Prepared Using Remarkably Simple TEMPO-Mediated Oxidation
por: Qing, Lin-Sen, et al.
Publicado: (2017)

Elucidation of the binding mechanism of astragaloside IV derivative with human serum albumin and its cardiotoxicity in zebrafish embryos
por: Wu, You-Jiao, et al.
Publicado: (2022)

Astragaloside IV Prevents Obesity-Associated Hypertension by Improving Pro-Inflammatory Reaction and Leptin Resistance
por: Jiang, Ping, et al.
Publicado: (2018)

Astragaloside IV ameliorates early diabetic nephropathy by inhibition of MEK1/2-ERK1/2-RSK2 signaling in streptozotocin-induced diabetic mice
por: Song, Gaofeng, et al.
Publicado: (2018)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Antihypertension effect of astragaloside IV during cerebral ischemia reperfusion in rats
por: Shen, Fengyan, et al.
Publicado: (2022)

Research on the interaction of astragaloside IV and calycosin in Astragalus membranaceus with HMGB1
por: Ye, Junyi, et al.
Publicado: (2023)

Astragaloside IV ameliorates experimental autoimmune myasthenia gravis by regulating CD4 + T cells and altering gut microbiota
por: Weng, Senhui, et al.
Publicado: (2023)

Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
por: Fan, Yuyan, et al.
Publicado: (2019)

Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022)

Astragaloside IV Ameliorates Isoprenaline-Induced Cardiac Fibrosis in Mice via Modulating Gut Microbiota and Fecal Metabolites
por: Du, Xu-Qin, et al.
Publicado: (2022)

Astragaloside IV Inhibits the Proliferation of Human Uterine Leiomyomas by Targeting IDO1
por: Qiu, Tiantian, et al.
Publicado: (2022)

Protective Effect and Possible Mechanisms of Astragaloside IV in Animal Models of Diabetic Nephropathy: A Preclinical Systematic Review and Meta-Analysis
por: Wang, Hong, et al.
Publicado: (2020)

Astragaloside IV attenuates neuroinflammation and ameliorates cognitive impairment in Alzheimer’s disease via inhibiting NF-κB signaling pathway
por: He, Li, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p5dog2vfarp9asdia2kh8u05tn